Ignite Creation Date:
2024-05-05 @ 4:44 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00309881
Status:
COMPLETED
Last Update Posted:
2016-10-03
First Post:
2006-03-29
Brief Title:
Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia CLL That Did Not Respond to Fludarabine CLL With Autoimmune Haemolytic Anemia AIHA or Richters Transformation RT
Sponsor:
German CLL Study Group
Organization:
German CLL Study Group
Organization Data
Organization:
German CLL Study Group
Class:
OTHER
Study ID:
CLL2G
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
German CLL Study Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None